Filter
2216
Filtered Results: 2216
Text search:
drugs
and
related
substances
act
Featured
Recommendations
243
New Publications
522
Language
Document type
No document type
1388
Guidelines
287
Studies & Reports
255
Manuals
137
Strategic & Response Plan
65
Training Material
44
Fact sheets
20
Situation Updates
9
Infographics
5
Brochures
4
Resource Platforms
2
Countries / Regions
India
111
Kenya
86
South Africa
84
Western and Central Europe
64
Global
52
Nigeria
46
Ethiopia
46
Uganda
41
Zambia
37
Ukraine
34
Tanzania
34
Ghana
33
Nepal
32
Myanmar / Burma
28
Namibia
27
Liberia
27
Sierra Leone
26
Latin America and the Carribbean
25
Eastern Europe
25
Malawi
21
Africa
19
Russia
19
Rwanda
17
Philippines
16
South–East Asia Region
16
Bangladesh
15
Botswana
15
Zimbabwe
14
Eswatini/ Swaziland
14
Syria
13
Indonesia
13
Asia
12
Lesotho
11
Cambodia
11
Tajikistan
8
Eastern Europe and Central Asia
7
Georgia
7
Afghanistan
6
USA
6
Germany
6
North Macedonia
5
Western Pacific Region
5
South Sudan
5
Pakistan
5
Guinea
4
East and Southern Africa
4
Moldova
4
Sri Lanka
4
Yemen
4
Colombia
3
Thailand
3
Cameroon
3
Senegal
3
Burkina Faso
3
Mozambique
3
Haiti
3
West and Central Africa
3
Middle East and North Africa
3
Jamaica
3
United Kingdom
3
Belarus
3
Vietnam
3
Sudan
3
Iraq
3
Mexico
2
Gambia
2
China
2
Iran
2
Albania
2
Canada
2
Fiji
2
Laos
2
Kyrgyzstan
2
Uzbekistan
2
Peru
2
Morocco
2
Hungary
2
Jordan
2
Congo, Democratic Republic of
2
Paraguay
2
Southern Africa
2
Argentina
2
Lebanon
2
Papua New Guinea
2
Poland
2
Bhutan
2
Switzerland
1
Timor Leste/ East Timor
1
Serbia
1
Australia
1
Benin
1
Kazakhstan
1
Chile
1
Singapore
1
Estonia
1
Bulgaria
1
Armenia
1
Venezuela
1
Saudi Arabia
1
Denmark
1
Belgium
1
Maldives
1
Mauritius
1
Tunisia
1
Norway
1
Portugal
1
Latvia
1
Brazil
1
Romania
1
Greece
1
Palestine
1
Libya
1
Somalia
1
Authors & Publishers
Publication Years
Category
Countries
778
Clinical Guidelines
156
Public Health
107
Women & Child Health
95
Capacity Building
51
Key Resources
46
Pharmacy & Technologies
30
Annual Report MEDBOX
1
Toolboxes
Mental Health
475
HIV
238
TB
115
Pharmacy
107
COVID-19
93
AMR
90
Caregiver
55
NCDs
41
Planetary Health
37
Rapid Response
33
Refugee
29
Disability
28
Conflict
28
Ebola
25
Global Health Education
21
Specific Hazards
18
NTDs
16
Natural Hazards
15
Polio
6
Health Financing Toolbox
5
Cholera
4
Zika
4
Social Ethics
3
"Some of the problems with our current drug policies stem from the fact that these policies have been largely bifurcated between two different and often contradictory approaches. One treats drug use as a crime that cannot be tolerated and should be punished; the other views addiction as a chronic re...
An Independent Report
of the West Africa Commission on Drugs
Information for families affected
Full eHandbook under: http://www.msh.org/resources/health-systems-in-action-an-ehandbook-for-leaders-and-managers
Effective supply management has the potential to make a powerful contribution to the reliable availability of essential medicines, which are a crucial part of the delivery of highqualit...
This block contains a wide variety of disorders that differ in severity (from uncomplicated intoxication and harmful use to obvious psychotic disorders and dementia), but that are all attributable to the use of one or more psychoactive substances (which may or may not have been medically prescribed)
Petersen et al. Int J Ment Health Syst (2016) 10:30 DOI 10.1186/s13033-016-0060-z
The handbook on supply chain management for HIV/AIDS commodities was written to assist program managers to plan and implement day–to-day management of all drugs and medical supplies for an HIV/AIDS program. Many of the suggested techniques described in this handbook are helpfu...
Indian markets caused a stir across the country.1
According to the Centre for Science and the Environment (CSE), a respected New Delhi-based NGO, most honey brands
sold in India contained varying amounts of antibiotics. Their consumption over time could induce resistance to antibiotics,
putting p...
Made under Section 5 (c) of the Tanzania Food, Drugs and Cosmetics Act, 2003 | Second Edition
The World Drug Report 2022 is aimed not only at fostering greater international cooperation to counter the impact of the world drug problem on health, governance and security, but also, with its special insights, at assisting Member States in anticipating and address-ing threats from drug markets an...
Good Manufacturing Practice (GMP) describes a set of principles and procedures that, when followed, ensure that medicines and related substances are of high quality, safety and efficacy. SAHPRA is a
participating authority of the Pharmaceutical Inspection Cooperation Scheme (jointly known as PIC/S)...
WHO mhGAP Guideline update
recommended
Update of the Mental Health Gap Action Programme
(mhGAP) Guideline for Mental, Neurological and Substance use Disorders May 2015
South African Health Review 2019
recommended
22nd edition
The purpose of the SAHR has always been to analyse and assess progress and challenges in key areas of the health system, and to propose recommendations for improvement. We are pleased to continue this tradition in the 2019 edition, which presents a unique collection of perspectives on ...
2nd revised edition. Accessed Apri. 17, 2019
Prevention strategies based on scientific evidence working with families, schools, and communities can ensure that children and youth, especially the most marginalized and poor, grow and stay healthy and safe into adulthood and old age. For every dollar ...
Antimicrobials are precious agents for combating infectious diseases and had saved millions of lives throughout the world. However, the current trend of increasing antimicrobial resistance (AMR) has become a global health problem with increased morbidity and mortality in infectious diseases. Sri La...
This report aims to improve the assessment of mental health needs in the Americas by providing an updated and nuanced picture of: (a) the disability resulting from mental, substance use, and specific neurological disorders, plus self-harm, alone and in combination with premature mortality; (b) the i...
